Barry Tanne
Family Medicine · Marysville, WANPI 1265497853
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,024 and has fallen 76.0% since, to $246 in 2025. Among family medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 134 payments — averaging $22.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$654
- Amarin Pharma, Inc.$486
- Johnson & Johnson$450
- AstraZeneca$372
- Amgen$252
- Kaneka Medical America LLC$246
- plus $607 from 10 others
What the payments were for
- Food & beverage$3,053100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 28 | $654 |
| Amarin Pharma, Inc. | 22 | $486 |
| Johnson & Johnson | 26 | $450 |
| AstraZeneca | 20 | $372 |
| Amgen | 6 | $252 |
| Kaneka Medical America LLC | 1 | $246 |
| Regeneron | 1 | $107 |
| Pfizer | 7 | $99 |
| AbbVie(2 entities) | 5 | $98 |
| Novartis | 4 | $64 |
| Sanofi-aventis U.S. LLC | 3 | $61 |
| Novo Nordisk | 4 | $55 |
| Bayer | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Melinta Therapeutics, LLC | 2 | $31 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apheresis Machine$246
- Vascepa$118
- EVENITY$109
- PRALUENT$107
- XARELTO$100
How this compares
$3,067 in reported general payments places this provider in the 90th percentile of 2,275 family medicine providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 16 | $380 |
| Atorvastatin Calcium | 17 | $337 |
| Levothyroxine Sodium | 13 | $237 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Marysville
- Kevin HatfieldSeattle$527K
- Marta KazymyraBlaine$222K
- Donella YoungDavenport$175K
- Robert McIntyreSeattle$107K
- James MorenBellingham$106K
- Marshall BrownPasco$70K
- Cynthia CoteMaple Valley$66K
- Greg LedgerwoodBrewster$66K
- Daniel RivasBurien$50K
- Kent WalkerSumner$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.